GlassScriptPhysician profile
Beatrice Burke
NPI 1033298625
$1,553.96
in general payments reported to CMS, 2019-2025
20 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $95.56 · 2021: $311 · 2022: $91.66 · 2023: $202 · 2024: $202 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $380.81 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $257.13 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $174.20 | 2019-2020 | |
| Pfizer INC. | $111.02 | 2019-2022 | |
| Astellas Pharma US INC | $86.01 | 2025 | Veozah |
| Biogen, INC. | $68.73 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $67.53 | 2023-2025 | Myosure Tissue Removal Device, Novasure, Aptima |
| Therapeuticsmd, INC. | $60.09 | 2019-2021 | |
| Daiichi Sankyo INC. | $58.42 | 2019-2021 | |
| Coopersurgical, INC. | $46.68 | 2019-2025 | Paragard T 380a |
| Exact Sciences Corporation | $42.78 | 2023 | Cologuard Collection Kit |
| Ethicon US, LLC | $34.57 | 2024 | Ethicon |
| Bayer Healthcare Pharmaceuticals INC. | $33.97 | 2019 | |
| Avion Pharmaceuticals | $27.23 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $22.27 | 2023 | Myfembree |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $21.43 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.47 | 2023 | Xifaxan |
| Vertical Pharmaceuticals, LLC | $14.91 | 2019 | |
| Roche Diagnostics Corporation | $14.20 | 2019 | |
| Allergan, INC. | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beatrice Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.